ANO1 and cancer: Although pharmacological inhibition of ANO1 reportedly inhibits the growth of various cancer cells [14,15,16,17,18,19], the potency, selectivity, safety, stability and mechanism of action of ANO1 inhibitors in NSCLC have not been identified [14,15,16,17,18,19].